# Filing Detail

Form 424B1 - Prospectus [Rule 424(b)(1)]:
SEC Accession No. 0001193125-17-345863
Filing Date
2017-11-17
Accepted
2017-11-16 21:30:56
Documents
10

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B1 | d427310d424b1.htm | 424B1 | 2548546
2 | GRAPHIC | g427310g13u57.jpg | GRAPHIC | 111203
3 | GRAPHIC | g427310g33a79.jpg | GRAPHIC | 131109
4 | GRAPHIC | g427310g33c79.jpg | GRAPHIC | 49256
5 | GRAPHIC | g427310g39n62.jpg | GRAPHIC | 77834
6 | GRAPHIC | g427310g52l47_color.jpg | GRAPHIC | 111633
7 | GRAPHIC | g427310g58p18.jpg | GRAPHIC | 97884
8 | GRAPHIC | g427310g59g46_color.jpg | GRAPHIC | 90204
9 | GRAPHIC | g427310g79v47.jpg | GRAPHIC | 49951
10 | GRAPHIC | g427310g87d19.jpg | GRAPHIC | 35704
| Complete submission text file | 0001193125-17-345863.txt |  | 3590482

Mailing Address 890 WINTER STREET, SUITE 230 WALTHAM MA 02451
Business Address 890 WINTER STREET, SUITE 230 WALTHAM MA 02451 781-819-5704
Arsanis, Inc. (Filer) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B1 | Act: 33 | File No.: 333-221050 | Film No.: 171209598
SIC: 2836 Biological Products, (No Diagnostic Substances)